PEPTIDES IDENTIFIED FROM THE TYPE I DIABETES ASSOCIATED MHC CLASS I-H2-KD
从 I 型糖尿病相关 MHC I-H2-KD 类中鉴定出的肽
基本信息
- 批准号:7355215
- 负责人:
- 金额:$ 0.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-01 至 2007-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The repertoire of peptides bound by major histocompatability complexes (MHC) determines the fate of important biological outcomes such as the cellular defense and immune responses to foreign invaders or in some aberrant cases reactivity to self antigens. Detailed analyses of naturally processed peptides from class I and II MHC molecules have revealed certain general features, for example the lengths of naturally processed peptides selected by class I MHC molecules are usually restricted to 8-10-mers whereas those selected by class II MHC molecules are longer and more variable, usually between 14-24-mer. More importantly, detailed analyses of naturally processed peptides have addressed key issues regarding the specificity of peptide-selection among closely related MHC molecules, which was not evident in prior studies involving synthetic peptide libraries. In this analyses, we sought to identify the nature and motif of peptides that are selected by the class I MHC molecule, H-2Kd. We selected H-2Kd because it may play a significant role in several areas of disease including: responses against viral and bacterial pathogens, autoimmune diabetes, tumor immunology, and the efficacy of peptide-based tumor vaccines. Results from our analyses of large numbers of peptides selected by H-2Kd have firmly established the peptide-binding motif. Although a large fraction of naturally selected peptides were 8 to 10 amino acids in length, there were a significant fraction that were of longer length, some as long as 18-mers. Binding studies demonstrated that while the short peptides bound with higher affinity and formed long-lived peptide-MHC complexes, the longer peptides bound weakly and had a fast dissociation rate. Trimming the long peptides did not improve binding interactions and conversely extending the 9-mer naturally processed epitopes did not decrease binding. Finally, the mode of binding of the longer peptides was investigated. Results from these experiments demonstrate that the Naturally processed peptides selected by H-2Kd varied in length from 8-mers to 18-mers ? although most peptides were 8-10 amino acids, there was a significant fraction that were 10 amino acids in length. The immunological significance of these peptides is currently under investigation.
这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金,因此可能会出现在其他CRISE条目中。列出的机构是针对中心的,而不一定是针对调查员的机构。主要组织相容性复合体(MHC)结合的多肽决定了重要生物学结果的命运,如对外来入侵的细胞防御和免疫反应,或者在某些异常情况下对自身抗原的反应。对来自第I类和第II类MHC分子的自然加工多肽的详细分析揭示了某些一般特征,例如,由第I类MHC分子选择的自然加工多肽的长度通常限制在8-10-MERS,而由第II类MHC分子选择的自然加工多肽的长度更长,变化更大,通常在14-24聚体之间。更重要的是,对自然处理的多肽的详细分析解决了关于在密切相关的MHC分子中选择多肽的特异性的关键问题,这在以前涉及合成多肽文库的研究中并不明显。在这一分析中,我们试图确定由I类MHC分子H-2Kd选择的多肽的性质和基序。我们选择H-2Kd是因为它可能在几个疾病领域发挥重要作用,包括:对病毒和细菌病原体的反应、自身免疫性糖尿病、肿瘤免疫学以及基于多肽的肿瘤疫苗的疗效。我们对H-2Kd筛选出的大量多肽的分析结果已经确定了多肽结合的基序。虽然自然选择的多肽有很大一部分是8到10个氨基酸的长度,但也有相当一部分的长度更长,有些长达18-MERS。结合研究表明,短肽结合亲和力较高,形成长寿期肽-MHC复合体时,长肽结合较弱,解离速度较快。修剪长肽不会改善结合相互作用,相反,延长9-聚体自然处理的表位并不会减少结合。最后,对较长多肽的结合方式进行了研究。这些实验结果表明,H-2Kd选择的天然加工多肽的长度从8-MERS到18-MERS?虽然大多数多肽是8-10个氨基酸,但也有相当一部分是10个氨基酸的长度。这些多肽的免疫学意义目前正在研究中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EMIL Raphael UNANUE其他文献
EMIL Raphael UNANUE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EMIL Raphael UNANUE', 18)}}的其他基金
Identification of relevant peptides involved in the initiation and progression of autoimmune diabetes
鉴定参与自身免疫性糖尿病发生和进展的相关肽
- 批准号:
10246429 - 财政年份:2018
- 资助金额:
$ 0.16万 - 项目类别:
Identification of relevant peptides involved in the initiation and progression of autoimmune diabetes
鉴定参与自身免疫性糖尿病发生和进展的相关肽
- 批准号:
9689765 - 财政年份:2018
- 资助金额:
$ 0.16万 - 项目类别:
AUTOIMMUNE DIABETES: EARLY EVENTS IN ISLETS OF LANGERHANS
自身免疫性糖尿病:朗格汉斯岛的早期事件
- 批准号:
9197630 - 财政年份:2015
- 资助金额:
$ 0.16万 - 项目类别:
CHARACTERIZATION OF ANTIGENIC PEPTIDES PRESENTED BY I-AG7
I-AG7 呈现的抗原肽的表征
- 批准号:
8361393 - 财政年份:2011
- 资助金额:
$ 0.16万 - 项目类别:
IDENTIFICATION OF MODIFIED AND NATURAL HEL PEPTIDE FRAGMENTS PRESENTED BY MHC
MHC 呈现的修饰和天然 HEL 肽片段的鉴定
- 批准号:
8361330 - 财政年份:2011
- 资助金额:
$ 0.16万 - 项目类别:
IDENTIFICATION OF MODIFIED AND NATURAL HEL PEPTIDE FRAGMENTS PRESENTED BY MHC
MHC 呈现的修饰和天然 HEL 肽片段的鉴定
- 批准号:
8168678 - 财政年份:2010
- 资助金额:
$ 0.16万 - 项目类别:
PEPTIDES IDENTIFIED FROM THE TYPE I DIABETES ASSOCIATED MHC CLASS I-H2-KD
从 I 型糖尿病相关 MHC I-H2-KD 类中鉴定出的肽
- 批准号:
8168690 - 财政年份:2010
- 资助金额:
$ 0.16万 - 项目类别:
CHARACTERIZATION OF ANTIGENIC PEPTIDES PRESENTED BY I-AG7
I-AG7 呈现的抗原肽的表征
- 批准号:
8168793 - 财政年份:2010
- 资助金额:
$ 0.16万 - 项目类别:
相似海外基金
Cell biological basis of a newly identified form of developmental and epileptic encephalopathy caused by variants in DENND5A, a guanine nucleotide exchange factor for Rab GTPases
由 DENND5A 变异引起的一种新发现的发育性和癫痫性脑病的细胞生物学基础,DENND5A 是 Rab GTP 酶的鸟嘌呤核苷酸交换因子
- 批准号:
489016 - 财政年份:2023
- 资助金额:
$ 0.16万 - 项目类别:
Operating Grants
A Priority Setting Partnership to Establish a Patient, Caregiver, and Clinician-identified Research Agenda for Adolescent and Young Adult Cancer in Canada
建立优先合作伙伴关系,以建立患者、护理人员和临床医生确定的加拿大青少年和年轻人癌症研究议程
- 批准号:
480840 - 财政年份:2023
- 资助金额:
$ 0.16万 - 项目类别:
Miscellaneous Programs
Biological validation of phage host-range identified by proximity guided metagenomics
通过邻近引导宏基因组学鉴定噬菌体宿主范围的生物学验证
- 批准号:
10761394 - 财政年份:2023
- 资助金额:
$ 0.16万 - 项目类别:
Placental identified NHIP regulating neuronal oxidative stress in autism
胎盘发现 NHIP 调节自闭症神经元氧化应激
- 批准号:
10717990 - 财政年份:2023
- 资助金额:
$ 0.16万 - 项目类别:
Elucidation of the pathogenesis of glucocorticoid-induced osteoporosis targeting newly identified circulating osteoclast precursor cells
针对新发现的循环破骨细胞前体细胞阐明糖皮质激素诱导的骨质疏松症的发病机制
- 批准号:
23K08707 - 财政年份:2023
- 资助金额:
$ 0.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Functional Analysis of a Novel Heart Failure Target Molecule Identified by Single-Cell Omics Analysis
单细胞组学分析鉴定的新型心力衰竭靶分子的功能分析
- 批准号:
23K15133 - 财政年份:2023
- 资助金额:
$ 0.16万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigation of a newly identified group of neurons regulating sleep and feeding behaviors.
对一组新发现的调节睡眠和进食行为的神经元的研究。
- 批准号:
10659498 - 财政年份:2023
- 资助金额:
$ 0.16万 - 项目类别:
Dissecting GWAS Identified Risk Variants in Parkinson's Disease – Functional Role of GPNMB in the Pathogenesis of PD
剖析 GWAS 确定的帕金森病风险变异 — GPNMB 在帕金森病发病机制中的功能作用
- 批准号:
10680117 - 财政年份:2023
- 资助金额:
$ 0.16万 - 项目类别:
Elucidation of the mechanism of maintaining hematopoietic stem cells by newly identified bone marrow mesenchymal stem cells.
阐明新鉴定的骨髓间充质干细胞维持造血干细胞的机制。
- 批准号:
23H02935 - 财政年份:2023
- 资助金额:
$ 0.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Therapeutic targets identified by pathway analysis of anti-inflammatory astrocyte in CNS inflammation
通过中枢神经系统炎症中抗炎星形胶质细胞通路分析确定的治疗靶点
- 批准号:
23H02639 - 财政年份:2023
- 资助金额:
$ 0.16万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




